Unique ID issued by UMIN | UMIN000004553 |
---|---|
Receipt number | R000005441 |
Scientific Title | Treatment of paroxysmal atrial fibrillation with pill-in-the-pocket approach-comparison of propafenone and flecainide- |
Date of disclosure of the study information | 2010/11/13 |
Last modified on | 2017/05/19 10:34:19 |
Treatment of paroxysmal atrial fibrillation with pill-in-the-pocket approach-comparison of propafenone and flecainide-
F-PITPA study
Treatment of paroxysmal atrial fibrillation with pill-in-the-pocket approach-comparison of propafenone and flecainide-
F-PITPA study
Japan |
Recent-onset atrial fibrillation
Medicine in general |
Others
NO
Compare the efficacy of propafenone and flecainide on the termination of recent-onset atrial fibrillation in Japanese
Efficacy
Confirmatory
Pragmatic
Not applicable
Termination of atrial fibrillation within 120 min after treatment of propafenone or flecainide
Safety (blood pressure and proarrhythmia)
Plasma drug concentration
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
Oral loading of propafenon, 150 mg q.d.
Oral loading of flecainide,100 mg q.d.
18 | years-old | <= |
75 | years-old | >= |
Male and Female
The inclusion criteria were an age of 18 to 75 years, an episode of electrocardiographically documented atrial fibrillation of recent onset (less than 48 hours earlier), a mean heart rate of more than 70 beats per minute, and a systolic pressure of 100 mmHg or more.
Patients were excluded if they had one or more of the following findings: electrocardiographic
evidence of ventricular pre-excitation or bundlebranch block (QRS interval >120 msec), a previous
episode of atrial fibrillation lasting seven days or more, ischemic heart disease, dilated or hypertrophic
cardiomyopathy, a history of heart failure, severe valvular heart disease, chronic cor pulmonale,
left ventricular dysfunction (ejection fraction, 50 percent), a long QT interval or the Brugada
syndrome, the bradycardia-tachycardia syndrome (resting heart rate, 50 beats per minute, or repetitive
sinoatrial blocks during waking hours), documentation of previous episodes of second or third-degree atrioventricular block, previous thromboembolic episodes, acute disease, very severe chronic diseases (e.g., muscular dystrophies or systemic collagen diseases), renal or hepatic insufficiency, previous hypokalemia (potassium level, <3 mmol per liter), suspected or known pregnancy, a known intolerance of flecainide or current propafenone, or current prophylactic antiarrhythmic treatment.
50
1st name | |
Middle name | |
Last name | Yukio Ozaki |
Fujita Health University School of Medicine
Department of Cardiology
1-98 Dengakugakubo, Kutsukake-cho,
0562-9-2312
enwatan@fujita-hu.ac.jp
1st name | |
Middle name | |
Last name | Eiichi Watanabe |
Fujita Health University School of Medicine
Department of Cardiology
1-98 Dengakugakubo, Kutsukake-cho,
0562-93-2312
enwatan@fujita-hu.ac.jp
Fujita Health University School of Medicine
Fujita Health University School of Medicine
Other
Japan
None
None
NO
藤田保健衛生大学病院
2010 | Year | 11 | Month | 13 | Day |
Published
Completed
2010 | Year | 10 | Month | 14 | Day |
2010 | Year | 11 | Month | 01 | Day |
2012 | Year | 12 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2013 | Year | 05 | Month | 01 | Day |
2010 | Year | 11 | Month | 13 | Day |
2017 | Year | 05 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005441